Browsing Tag
Heart Attack
12 posts
FDA approves Amgen’s Repatha for heart attack and stroke prevention
In a significant advancement for cardiovascular disease management, Amgen’s Repatha (evolocumab) has received approval from the U.S. Food…
December 9, 2017
TiGenix reports success for AlloCSC-01 in Phase I/II heart failure study
TiGenix, a Belgium-based biopharmaceutical company, has announced promising results from its Phase I/II study assessing the safety and…
March 13, 2017